DK1458364T3 - Farmaceutiske kompositioner omfattende metformin og glibenclamid til behandling af type-II diabetes mellitus - Google Patents

Farmaceutiske kompositioner omfattende metformin og glibenclamid til behandling af type-II diabetes mellitus

Info

Publication number: DK1458364T3
Authority: DK; Denmark
Prior art keywords: glibenclamide; metformin; treatment; type; pharmaceutical compositions
Prior art date: 2001-11-29

Application number

DK02791739T

Other languages

Danish (da)

English (en)

Inventor

Alessandro Tosetti

Mauro Guiducci

Giovanni Viti

Original Assignee

Menarini Int Operations Lu Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-11-29

Filing date

2002-11-29

Publication date

2008-06-23

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11442301&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1458364(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2002-11-29 Application filed by Menarini Int Operations Lu Sa filed Critical Menarini Int Operations Lu Sa

2008-06-23 Application granted granted Critical

2008-06-23 Publication of DK1458364T3 publication Critical patent/DK1458364T3/da

Links

229960004580 glibenclamide Drugs 0.000 title 1
ZNNLBTZKUZBEKO-UHFFFAOYSA-N glyburide Chemical compound COC1=CC=C(Cl)C=C1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCCCC2)C=C1 ZNNLBTZKUZBEKO-UHFFFAOYSA-N 0.000 title 1
XZWYZXLIPXDOLR-UHFFFAOYSA-N metformin Chemical compound CN(C)C(=N)NC(N)=N XZWYZXLIPXDOLR-UHFFFAOYSA-N 0.000 title 1
229960003105 metformin Drugs 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1
208000001072 type 2 diabetes mellitus Diseases 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Diabetes (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Emergency Medicine (AREA)
Hematology (AREA)
Obesity (AREA)
Endocrinology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

DK02791739T 2001-11-29 2002-11-29 Farmaceutiske kompositioner omfattende metformin og glibenclamid til behandling af type-II diabetes mellitus DK1458364T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IT2001FI000230A ITFI20010230A1 (it)	2001-11-29	2001-11-29	Composizioni farmaceutiche per il trattamento del diabete mellito di tipo ii
PCT/EP2002/013497 WO2003045355A1 (fr)	2001-11-29	2002-11-29	Compositions pharmaceutiques comprenant le glibenclamide et la metformine destinees au traitement du diabete sucre de type ii

Publications (1)

Publication Number	Publication Date
DK1458364T3 true DK1458364T3 (da)	2008-06-23

Family

ID=11442301

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK02791739T DK1458364T3 (da)	2001-11-29	2002-11-29	Farmaceutiske kompositioner omfattende metformin og glibenclamid til behandling af type-II diabetes mellitus

Country Status (39)

Country	Link
US (1)	US20050053661A1 (fr)
EP (1)	EP1458364B1 (fr)
JP (1)	JP4474162B2 (fr)
KR (1)	KR20040079898A (fr)
CN (1)	CN1596103B (fr)
AR (1)	AR037407A1 (fr)
AT (1)	ATE387190T1 (fr)
AU (1)	AU2002358061B2 (fr)
BR (1)	BR0214403A (fr)
CA (1)	CA2466677A1 (fr)
CO (1)	CO5590906A2 (fr)
CY (1)	CY1107966T1 (fr)
DE (1)	DE60225331T2 (fr)
DK (1)	DK1458364T3 (fr)
EA (1)	EA006766B1 (fr)
EG (1)	EG24124A (fr)
ES (1)	ES2302862T3 (fr)
HN (1)	HN2002000341A (fr)
HR (1)	HRP20040501A2 (fr)
HU (1)	HUP0402154A3 (fr)
IL (1)	IL162143A0 (fr)
IT (1)	ITFI20010230A1 (fr)
MA (1)	MA27087A1 (fr)
MX (1)	MXPA04004974A (fr)
MY (1)	MY141243A (fr)
NO (1)	NO20042713L (fr)
NZ (1)	NZ533779A (fr)
PA (1)	PA8559801A1 (fr)
PE (1)	PE20030580A1 (fr)
PL (1)	PL206016B1 (fr)
PT (1)	PT1458364E (fr)
RS (1)	RS50937B (fr)
SI (1)	SI1458364T1 (fr)
SV (1)	SV2004001415A (fr)
TN (1)	TNSN04095A1 (fr)
UA (1)	UA81615C2 (fr)
UY (1)	UY27549A1 (fr)
WO (1)	WO2003045355A1 (fr)
ZA (1)	ZA200404880B (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2725833A1 (fr) *	2001-01-12	2002-07-18	Sun Pharmaceutical Industries Limited	Systeme de liberation espacee de medicaments
WO2003105809A1 (fr)	2002-06-17	2003-12-24	Themis Laboratories Private Limited	Comprimes multicouche contenant des thiazolidinediones et des biguanides et procedes de production desdits comprimes
US9060941B2 (en)	2002-09-20	2015-06-23	Actavis, Inc.	Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US7785627B2 (en)	2002-09-20	2010-08-31	Watson Pharmaceuticals, Inc.	Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
WO2004096201A1 (fr)	2003-04-29	2004-11-11	Orexigen Therapeutics, Inc.	Compositions influant sur la perte de poids
PE20061245A1 (es) *	2005-03-30	2007-01-06	Generex Pharm Inc	Composiciones para la transmision transmucosa oral de la metformina
TWI471145B (zh) *	2005-06-13	2015-02-01	Bristol Myers Squibb & Gilead Sciences Llc	單一式藥學劑量型
DK2089005T3 (da) *	2006-11-09	2010-07-19	Orexigen Therapeutics Inc	Lagdelte farmaceutiske formuleringer omfattende et hurtigt opløsende mellemlag
ITMI20062254A1 (it) *	2006-11-24	2008-05-25	Acraf	Uso di un acido metossi-alcanoico dell'indazolo per preparare una composizione farmaceutca
WO2009158114A1 (fr)	2008-05-30	2009-12-30	Orexigen Therapeutics, Inc.	Procédés pour traiter des pathologies des graisses viscérales
CA2638240C (fr)	2008-08-29	2010-02-02	Alexander Macgregor	Methode de traitement des anomalies de la glycemie et des variations de la glycemie
RU2398572C1 (ru) *	2009-05-18	2010-09-10	Государственное образовательное учреждение высшего профессионального образования "Санкт-Петербургская государственная медицинская академия им. И.И. Мечникова Федерального агентства по здравоохранению и социальному развитию"	Способ лечения больных сахарным диабетом 2 типа
CN102724878A (zh)	2010-01-11	2012-10-10	奥雷西根治疗公司	在重度抑郁症患者中提供体重减轻疗法的方法
RU2483717C2 (ru) *	2010-11-22	2013-06-10	Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН")	Фармацевтическая композиция для лечения диабета (варианты)
US9480663B2 (en)	2011-01-07	2016-11-01	Elcelyx Therapeutics, Inc.	Biguanide compositions and methods of treating metabolic disorders
US9211263B2 (en)	2012-01-06	2015-12-15	Elcelyx Therapeutics, Inc.	Compositions and methods of treating metabolic disorders
US11974971B2 (en)	2011-01-07	2024-05-07	Anji Pharmaceuticals Inc.	Compositions and methods for treating metabolic disorders
US8796338B2 (en)	2011-01-07	2014-08-05	Elcelyx Therapeutics, Inc	Biguanide compositions and methods of treating metabolic disorders
PT2661266T (pt)	2011-01-07	2020-11-30	Anji Pharma Us Llc	Terapias com base em ligandos do recetor quimiossensorial
US11759441B2 (en)	2011-01-07	2023-09-19	Anji Pharmaceuticals Inc.	Biguanide compositions and methods of treating metabolic disorders
US9572784B2 (en)	2011-01-07	2017-02-21	Elcelyx Therapeutics, Inc.	Compositions comprising statins, biguanides and further agents for reducing cardiometabolic risk
SG10201901922VA (en)	2012-01-06	2019-04-29	Elcelyx Therapeutics Inc	Compositions and methods for treating metabolic disorders
MX2014008190A (es)	2012-01-06	2015-02-04	Elcelyx Therapeutics Inc	Composiciones de biguanida y métodos para tratar transtornos metabólicos.
HUE072188T2 (hu)	2012-06-06	2025-10-28	Nalpropion Pharmaceuticals Llc	Készítmény magas kardiovaszkuláris kockázatú túlsúlyos és elhízott páciensek kezelésére szolgáló eljárásban történõ alkalmazásra
KR20170083071A (ko)	2014-11-11	2017-07-17	시오노기 앤드 컴파니, 리미티드	광에 대해서 불안정한 약물을 함유하는 다층 정제
KR101750690B1 (ko) *	2015-10-28	2017-06-27	주식회사 종근당	메트포르민 및 로베글리타존을 포함하는 약제학적 조성물
CN105596339A (zh) *	2015-12-23	2016-05-25	青岛海之源智能技术有限公司	一种二甲双胍阿昔莫司复方组合物及制备方法
LT3804714T (lt)	2018-05-31	2025-03-10	Hua Medicine (Shanghai) Ltd.	Farmacinis derinys ir kompozicija, ir derinio preparatas, kurio sudėtyje yra gliukokinazės aktyvatorius ir biguanido hipoglikeminis vaistas, taip pat jų gamybos būdas ir panaudojimas
CN110128305A (zh) *	2019-05-10	2019-08-16	天津大学	二甲双胍-甲苯磺丁脲新盐型、其制备方法及医药用途
JP2021120357A (ja) *	2020-01-30	2021-08-19	サンノーバ株式会社	錠剤
GB2599950A (en) *	2020-10-16	2022-04-20	Zentiva Ks	Pharmaceutical compositions with low amounts of nitrosamine impurities and methods for producing the same
CN113143940A (zh) *	2020-12-30	2021-07-23	成都恒瑞制药有限公司	一种抗糖尿病药物组合物的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2347531A1 (de)	1973-09-21	1975-04-30	Hoechst Ag	Arzneizubereitungen zur oralen diabetes-behandlung
IT1276130B1 (it) *	1995-11-14	1997-10-27	Gentili Ist Spa	Associazione glibenclamide-metformina, composizioni farmaceutiche che la contengono e loro uso nel trattamento del diabete mellito di tipo
EP1063973B1 (fr) *	1998-03-19	2016-11-16	Bristol-Myers Squibb Company	Systeme d'apport a liberation lente biphasique destine a des medicaments a solubilite elevee et procede associe
DK0974356T3 (da) *	1998-07-15	2003-10-27	Merck Sante Sas	Tabletter omfattende en kombination af metformin og glibenclamid
US6780432B1 (en) *	2000-05-01	2004-08-24	Aeropharm Technology, Inc.	Core formulation
CA2725833A1 (fr) *	2001-01-12	2002-07-18	Sun Pharmaceutical Industries Limited	Systeme de liberation espacee de medicaments

2001
- 2001-11-29 IT IT2001FI000230A patent/ITFI20010230A1/it unknown
2002
- 2002-11-22 AR ARP020104498A patent/AR037407A1/es unknown
- 2002-11-25 MY MYPI20024393A patent/MY141243A/en unknown
- 2002-11-26 PE PE2002001140A patent/PE20030580A1/es not_active Application Discontinuation
- 2002-11-26 UY UY27549A patent/UY27549A1/es not_active Application Discontinuation
- 2002-11-27 EG EG2002111281A patent/EG24124A/xx active
- 2002-11-28 SV SV2002001415A patent/SV2004001415A/es not_active Application Discontinuation
- 2002-11-29 EA EA200400664A patent/EA006766B1/ru not_active IP Right Cessation
- 2002-11-29 BR BR0214403-4A patent/BR0214403A/pt not_active IP Right Cessation
- 2002-11-29 US US10/497,022 patent/US20050053661A1/en not_active Abandoned
- 2002-11-29 EP EP02791739A patent/EP1458364B1/fr not_active Expired - Lifetime
- 2002-11-29 UA UA20040504085A patent/UA81615C2/ru unknown
- 2002-11-29 DE DE60225331T patent/DE60225331T2/de not_active Expired - Lifetime
- 2002-11-29 JP JP2003546858A patent/JP4474162B2/ja not_active Expired - Lifetime
- 2002-11-29 NZ NZ533779A patent/NZ533779A/en not_active IP Right Cessation
- 2002-11-29 IL IL16214302A patent/IL162143A0/xx not_active IP Right Cessation
- 2002-11-29 KR KR10-2004-7006874A patent/KR20040079898A/ko not_active Ceased
- 2002-11-29 HU HU0402154A patent/HUP0402154A3/hu unknown
- 2002-11-29 HN HN2002000341A patent/HN2002000341A/es unknown
- 2002-11-29 AT AT02791739T patent/ATE387190T1/de not_active IP Right Cessation
- 2002-11-29 CA CA002466677A patent/CA2466677A1/fr not_active Abandoned
- 2002-11-29 DK DK02791739T patent/DK1458364T3/da active
- 2002-11-29 SI SI200230693T patent/SI1458364T1/sl unknown
- 2002-11-29 AU AU2002358061A patent/AU2002358061B2/en not_active Ceased
- 2002-11-29 HR HRP20040501 patent/HRP20040501A2/hr not_active Application Discontinuation
- 2002-11-29 PA PA20028559801A patent/PA8559801A1/es unknown
- 2002-11-29 PT PT02791739T patent/PT1458364E/pt unknown
- 2002-11-29 CN CN028236920A patent/CN1596103B/zh not_active Expired - Fee Related
- 2002-11-29 WO PCT/EP2002/013497 patent/WO2003045355A1/fr not_active Ceased
- 2002-11-29 MX MXPA04004974A patent/MXPA04004974A/es active IP Right Grant
- 2002-11-29 ES ES02791739T patent/ES2302862T3/es not_active Expired - Lifetime
- 2002-11-29 PL PL369851A patent/PL206016B1/pl not_active IP Right Cessation
2004
- 2004-05-24 MA MA27696A patent/MA27087A1/fr unknown
- 2004-05-28 RS YUP-473/04A patent/RS50937B/sr unknown
- 2004-05-28 TN TNP2004000095A patent/TNSN04095A1/en unknown
- 2004-06-21 ZA ZA200404880A patent/ZA200404880B/en unknown
- 2004-06-28 NO NO20042713A patent/NO20042713L/no not_active Application Discontinuation
- 2004-06-29 CO CO04061363A patent/CO5590906A2/es not_active Application Discontinuation
2008
- 2008-05-26 CY CY20081100543T patent/CY1107966T1/el unknown

Also Published As

Publication number	Publication date
CO5590906A2 (es)	2005-12-30
EG24124A (en)	2008-07-07
PL206016B1 (pl)	2010-06-30
IL162143A0 (en)	2005-11-20
EP1458364B1 (fr)	2008-02-27
NZ533779A (en)	2007-02-23
ES2302862T3 (es)	2008-08-01
CN1596103A (zh)	2005-03-16
PE20030580A1 (es)	2003-09-05
MY141243A (en)	2010-03-31
CN1596103B (zh)	2010-06-16
PT1458364E (pt)	2008-05-26
EA006766B1 (ru)	2006-04-28
RS50937B (sr)	2010-08-31
EA200400664A1 (ru)	2004-10-28
CY1107966T1 (el)	2013-09-04
HUP0402154A3 (en)	2008-04-28
JP4474162B2 (ja)	2010-06-02
HK1069974A1 (en)	2005-06-10
AU2002358061B2 (en)	2007-01-11
NO20042713L (no)	2004-07-16
AR037407A1 (es)	2004-11-10
SV2004001415A (es)	2004-05-07
EP1458364A1 (fr)	2004-09-22
UY27549A1 (es)	2003-06-30
UA81615C2 (ru)	2008-01-25
TNSN04095A1 (en)	2006-06-01
CA2466677A1 (fr)	2003-06-05
DE60225331D1 (de)	2008-04-10
PA8559801A1 (es)	2003-06-30
DE60225331T2 (de)	2009-02-26
HN2002000341A (es)	2009-12-07
AU2002358061A1 (en)	2003-06-10
SI1458364T1 (sl)	2008-08-31
US20050053661A1 (en)	2005-03-10
MA27087A1 (fr)	2004-12-20
ITFI20010230A1 (it)	2003-05-29
MXPA04004974A (es)	2004-08-11
JP2005518360A (ja)	2005-06-23
HUP0402154A2 (hu)	2005-02-28
KR20040079898A (ko)	2004-09-16
BR0214403A (pt)	2004-10-19
WO2003045355A1 (fr)	2003-06-05
ZA200404880B (en)	2005-07-29
PL369851A1 (en)	2005-05-02
RS47304A (sr)	2006-10-27
ATE387190T1 (de)	2008-03-15
HRP20040501A2 (en)	2004-12-31

Publication	Publication Date	Title
NO20042713L (no)	2004-07-16	Farmasoytiske preparater omfattende metformin og glibenklamid for behandling av type ll diabetes mellitus
NO20024175L (no)	2002-10-29	Azetidinderivater, deres fremstilling og farmasöytiske preparater inneholdende forbindelsene
DK1412357T3 (da)	2006-07-17	Beta-aminotetrahydroimidazo-(1,2-a)-pyraziner og tetrahydrotriazolo-(4,3-a)-pyraziner som dipeptidylpeptidaseinhibitorer til behandling eller forebyggelse af diabetes
DK1309324T3 (da)	2006-06-12	Antikonvulsive derivater egnede til behandling og forebyggelse af udvikling af type II diabetes mellitus og syndrom X
ATE204754T1 (de)	2001-09-15	Pharmazeutische zusammensetzung von metformin und fibrat, und ihre verwendung zur behandlung von hyperglykämie
DK1183020T3 (da)	2006-11-27	(3-trihalogenmethylphenoxy)(4-halogenphenyl) til behandling af insulinresistens og type 2-diabetes
NO20033726L (no)	2003-08-21	Xantin-derivater, fremstilling og anvendelse derav som et medikament
HUP0401665A3 (en)	2008-05-28	Alfa and beta-form crystal of an aminothiazolyl acetanilide derivative, their use and pharmaceutical compositions containing them
DK1572707T3 (da)	2006-08-14	Hidtil ukendte aromatiske fluorglycosidderivater, lægemidler indeholdende disse forbindelser og anvendelse heraf
ATE303802T1 (de)	2005-09-15	3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phen l enthaltendes arzneimittel mit verzögerter wirkstofffreisetzung
DK1484970T3 (da)	2013-10-07	Benzamider og sammensætninger omfattende benzamider til anvendelse som fungicider
NO20033100L (no)	2003-07-07	Uorganiske matrikssammensetninger og kompositter som inneholder matrikssammensetningen
IL194950A0 (en)	2011-08-01	Novel, arylsulfonamide compounds for the treatment of obesity, type ii diabetes and cns-disorders
DE50311318D1 (de)	2009-04-30	Neue substituierte imidazo-pyridinone und imidazo-pyridazinone, ihre herstellung und ihre verwendung als arzneimittel
DK1423376T3 (da)	2010-06-28	Bicyklisk forbindelse, fremstilling og anvendelse deraf
BRPI0312649A2 (pt)	2017-05-16	compostos, composições farmacêuticas contendo os mesmos, e processos de uso para os mesmos.
NO20022334D0 (no)	2002-05-15	Ny sammensetning og anvendelse
DK1395242T3 (da)	2006-10-30	Flydende farmaceutisk sammensætning
DE60204349D1 (de)	2005-06-30	4-(1,3,4-thiadiazolyl-2-yl)-1,4-diazabizyklo- 3.2.2 nonanderivate, ihre herstellung und ihre therapeutische verwendung
NO20044322L (no)	2004-10-12	Benzoksanon-avledede forbindelser, deres fremstilling og anvendelse som medikament
DK1322158T3 (da)	2012-11-19	Farmaceutiske præparater med langvarig frigivelse, som indeholder metformin, og fremgangsmåde til fremstilling deraf
NO20040860L (no)	2004-04-22	Farmasoytisk sammensetning som innbefatter lumiracoxib
DK1411917T3 (da)	2007-09-24	Carbamatforbindelser til anvendelse til forebyggelse eller behandling af bevægelsesforstyrrelser
DE60203537D1 (de)	2005-05-04	5ht1-rezeptoragonist enthaltendes arzneimittel
ATE350016T1 (de)	2007-01-15	Bicalutamid enthaltende pharmazeutische zusammensetzung